50 Participants Needed

Digital Thermal Monitoring for Endothelial Dysfunction

KM
DR
Overseen ByDristhi Ragoonanan
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This trial measures how well blood vessels work by checking finger temperature changes after stopping and restarting blood flow. It focuses on children and young adults undergoing a major medical procedure. The goal is to see if this method can effectively measure their vascular health.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications.

What data supports the idea that Digital Thermal Monitoring for Endothelial Dysfunction is an effective treatment?

The available research shows that Digital Thermal Monitoring (DTM) is useful for assessing vascular function, which is important for understanding endothelial dysfunction. One study found that DTM correlates with known coronary artery disease, suggesting it can effectively monitor vascular health. However, the research does not directly show DTM as a treatment but rather as a tool for assessment. There is no direct comparison to other treatments for endothelial dysfunction in the provided data.12345

What safety data exists for Digital Thermal Monitoring for Endothelial Dysfunction?

The safety of Digital Thermal Monitoring (DTM) for assessing endothelial dysfunction is supported by studies that demonstrate its noninvasive nature and its correlation with established methods like Doppler flow velocity. The VENDYS® device, used in a study with patients having Continuous Flow-Left Ventricular Assist Devices, showed no association with adverse events, indicating its safety in clinical settings.12367

Is Digital Thermal Monitoring a promising treatment for endothelial dysfunction?

Digital Thermal Monitoring is a promising treatment because it offers a non-invasive way to assess endothelial function, which is important for detecting early signs of heart disease. It uses temperature changes to evaluate how well blood vessels are working, making it easier to identify problems early on.128910

Research Team

DR

Dristhi Ragoonanan, MD

Principal Investigator

M.D. Anderson Cancer Center

Eligibility Criteria

This trial is for children and young adults aged 6-26 who are about to undergo or have recently had a hematopoietic cell transplant (HCT). It includes both recipients within a month before/after HCT and healthy donors. Participants must fit the device on their index finger without pain or difficulty, consent to join, and not have skin toxicity or neuropathy affecting device use.

Inclusion Criteria

I am a healthy donor aged 6-26 for hematopoietic cell transplantation.
I have had a stem cell transplant within the last month or plan to have one in the next two weeks.
Willing and eligible to enroll on PA19-0756
See 2 more

Exclusion Criteria

Any subject who does not consent/assent to participation.
You have an injury or deformity on your index finger that would make it impossible to wear the device comfortably.
I cannot use the device comfortably due to skin issues or nerve pain.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Assessment

Participants undergo a single measurement of vascular health using the Vendys II device

1 day
1 visit (in-person)

Follow-up

Participants are monitored for any adverse events following the assessment

4 weeks

Treatment Details

Interventions

  • Vendys II Device
Trial OverviewThe study is testing the Vendys II device's ability to measure vascular health in patients undergoing HCT. The FDA-approved tool assesses how well blood vessels can dilate by monitoring temperature changes in the finger after temporarily stopping blood flow.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Vendys II DeviceExperimental Treatment1 Intervention
Your participation in this study will be over after your blood vessel health is measured 1 time with the Vendys II device

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+

Findings from Research

The study successfully demonstrated a reliable method for assessing flow-mediated dilatation (FMD) in a rodent model using infrared pulse sensors, which is important for studying endothelial function in small animals.
Infusion of acetylcholine significantly increased the dilatation index, indicating enhanced endothelial function, while L-NAME reduced it, confirming the method's effectiveness in evaluating vascular responses similar to those observed in humans.
In vivo assessment of endothelial function in small animals using an infrared pulse detector.Liu, CC., Liu, WM., Wu, HT., et al.[2022]
The study demonstrated that using a thermography catheter in coronary arteries is safe and feasible, with no adverse events reported during the procedures on both rabbit and pig models.
The catheter caused acute but reversible de-endothelialization similar to that seen with intravascular ultrasound (IVUS), indicating that while there is some endothelial damage, it is not permanent and can be clinically acceptable.
Intravascular thermography: Immediate functional and morphological vascular findings.Verheye, S., De Meyer, GR., Krams, R., et al.[2019]
Endo-PAT testing, a new FDA-approved technology, was found to be highly reproducible and feasible for assessing endothelial function in a study of 30 healthy adolescents aged 13 to 19, with a high completion rate of 100%.
The testing resulted in a low median pain score of 1, indicating minimal discomfort for participants, which suggests that Endo-PAT could be a reliable and non-invasive method for evaluating cardiovascular health in young people.
Endothelial pulse amplitude testing: feasibility and reproducibility in adolescents.Selamet Tierney, ES., Newburger, JW., Gauvreau, K., et al.[2022]

References

1.China (Republic : 1949- )pubmed.ncbi.nlm.nih.gov
In vivo assessment of endothelial function in small animals using an infrared pulse detector. [2022]
Intravascular thermography: Immediate functional and morphological vascular findings. [2019]
Endothelial pulse amplitude testing: feasibility and reproducibility in adolescents. [2022]
Evaluation of digital thermal monitoring as a tool to assess perioperative vascular reactivity. [2023]
Relations between digital thermal monitoring of vascular function, the Framingham risk score, and coronary artery calcium score. [2019]
Endothelial Dysfunction-related Neurological Bleeds with Continuous Flow-Left Ventricular Assist Devices Measured by Digital Thermal Monitor. [2021]
Digital thermal monitoring (DTM) of vascular reactivity closely correlates with Doppler flow velocity. [2021]
Non-invasive assessment of endothelial function - relation between vasodilatory responses in skin microcirculation and brachial artery. [2019]
Novel Method to Assess Endothelial Function via Monitoring of Perfusion Response to Local Heating by Imaging Photoplethysmography. [2022]
Detection of frequency-dependent endothelial response to oscillatory shear stress using a microfluidic transcellular monitor. [2019]